NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 309 filers reported holding NEOGENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $176,089,273 | -25.2% | 14,316,201 | -2.2% | 0.00% | -33.3% |
Q2 2023 | $235,277,880 | -2.6% | 14,640,814 | +5.6% | 0.01% | 0.0% |
Q1 2023 | $241,486,397 | +91.1% | 13,870,557 | +1.4% | 0.01% | +100.0% |
Q4 2022 | $126,354,644 | +11.4% | 13,674,745 | +3.8% | 0.00% | 0.0% |
Q3 2022 | $113,434,000 | +4.5% | 13,174,708 | -1.1% | 0.00% | 0.0% |
Q2 2022 | $108,530,000 | -31.1% | 13,316,401 | +2.7% | 0.00% | -25.0% |
Q1 2022 | $157,592,000 | -64.1% | 12,970,503 | +0.9% | 0.00% | -60.0% |
Q4 2021 | $438,680,000 | -28.2% | 12,856,969 | +1.5% | 0.01% | -33.3% |
Q3 2021 | $611,218,000 | +10.9% | 12,670,362 | +3.9% | 0.02% | +7.1% |
Q2 2021 | $550,964,000 | -5.0% | 12,197,560 | +1.4% | 0.01% | -12.5% |
Q1 2021 | $580,141,000 | -3.5% | 12,028,639 | +7.7% | 0.02% | -5.9% |
Q4 2020 | $601,262,000 | +49.8% | 11,167,578 | +2.6% | 0.02% | +30.8% |
Q3 2020 | $401,465,000 | +15.3% | 10,882,750 | -3.2% | 0.01% | +8.3% |
Q2 2020 | $348,234,000 | +17.0% | 11,240,602 | +4.3% | 0.01% | -7.7% |
Q1 2020 | $297,571,000 | -3.2% | 10,777,645 | +2.5% | 0.01% | +30.0% |
Q4 2019 | $307,506,000 | +54.2% | 10,513,003 | +0.8% | 0.01% | +42.9% |
Q3 2019 | $199,456,000 | +11.2% | 10,431,825 | +27.6% | 0.01% | 0.0% |
Q2 2019 | $179,331,000 | +51.8% | 8,173,714 | +41.6% | 0.01% | +40.0% |
Q1 2019 | $118,105,000 | +128.8% | 5,772,487 | +41.0% | 0.01% | +150.0% |
Q4 2018 | $51,629,000 | -12.4% | 4,094,325 | +6.6% | 0.00% | 0.0% |
Q3 2018 | $58,939,000 | +45.2% | 3,839,641 | +24.0% | 0.00% | 0.0% |
Q2 2018 | $40,593,000 | +62.6% | 3,096,396 | +1.2% | 0.00% | +100.0% |
Q1 2018 | $24,968,000 | -4.7% | 3,059,815 | +3.5% | 0.00% | 0.0% |
Q4 2017 | $26,187,000 | -18.5% | 2,955,703 | +2.4% | 0.00% | -50.0% |
Q3 2017 | $32,133,000 | +31.6% | 2,887,074 | +6.0% | 0.00% | +100.0% |
Q2 2017 | $24,413,000 | +15.5% | 2,724,603 | +1.7% | 0.00% | 0.0% |
Q1 2017 | $21,144,000 | -1.4% | 2,679,783 | +7.1% | 0.00% | 0.0% |
Q4 2016 | $21,451,000 | +15.2% | 2,503,092 | +10.5% | 0.00% | 0.0% |
Q3 2016 | $18,616,000 | +8.7% | 2,264,646 | +6.3% | 0.00% | 0.0% |
Q2 2016 | $17,130,000 | +50.4% | 2,130,513 | +26.1% | 0.00% | 0.0% |
Q1 2016 | $11,386,000 | -9.4% | 1,689,394 | +5.8% | 0.00% | 0.0% |
Q4 2015 | $12,561,000 | +39.4% | 1,596,096 | +1.5% | 0.00% | – |
Q3 2015 | $9,011,000 | +16.2% | 1,572,494 | +9.7% | 0.00% | -100.0% |
Q2 2015 | $7,757,000 | +26.7% | 1,433,779 | +9.4% | 0.00% | – |
Q1 2015 | $6,121,000 | +22.9% | 1,310,781 | +9.7% | 0.00% | – |
Q4 2014 | $4,982,000 | -18.1% | 1,194,784 | +2.3% | 0.00% | – |
Q3 2014 | $6,086,000 | +134.2% | 1,168,215 | +49.2% | 0.00% | – |
Q2 2014 | $2,599,000 | -10.1% | 782,749 | -6.0% | 0.00% | – |
Q1 2014 | $2,891,000 | +16.9% | 832,878 | +22.0% | 0.00% | – |
Q4 2013 | $2,472,000 | +21.5% | 682,793 | +0.7% | 0.00% | – |
Q3 2013 | $2,035,000 | +31.2% | 678,301 | +74.1% | 0.00% | – |
Q2 2013 | $1,551,000 | – | 389,649 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |